三鑫医疗
(300453)
| 流通市值：34.07亿 | | | 总市值：48.76亿 |
| 流通股本：3.65亿 | | | 总股本：5.22亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,305,189,368.04 | 836,722,599.37 | 408,868,947.98 | 1,640,195,872.45 |
| 营业总成本 | 1,064,589,216.16 | 680,824,909.16 | 327,089,393.18 | 1,341,418,619.08 |
| 其他经营收益 | | | | |
| 营业利润 | 260,802,274.39 | 167,407,628.77 | 87,246,749.85 | 325,380,316.15 |
| 利润总额 | 257,013,471.04 | 163,089,918.43 | 87,349,209.48 | 324,242,542.41 |
| 净利润 | 229,562,089.77 | 145,049,066.03 | 75,422,347.94 | 290,268,722.64 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 229,562,089.77 | 145,049,066.03 | 75,422,347.94 | 290,268,722.64 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,391,795,846.58 | 906,661,452.46 | 918,065,036.55 | 925,200,310.53 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,652,810,801.16 | 1,558,526,738.6 | 1,525,826,191.32 | 1,503,685,529.28 |
| 资产总计 | 3,044,606,647.74 | 2,465,188,191.06 | 2,443,891,227.87 | 2,428,885,839.81 |
| 流动负债: | | | | |
| 流动负债合计 | 671,948,783.44 | 638,335,399.42 | 562,155,717.28 | 609,506,280.82 |
| 非流动负债: | | | | |
| 非流动负债合计 | 746,121,610.93 | 259,801,201.97 | 262,830,571.95 | 265,816,614.16 |
| 负债合计 | 1,418,070,394.37 | 898,136,601.39 | 824,986,289.23 | 875,322,894.98 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,546,410,795.62 | 1,493,271,762.93 | 1,528,586,691.9 | 1,458,293,542.45 |
| 股东权益合计 | 1,626,536,253.37 | 1,567,051,589.67 | 1,618,904,938.64 | 1,553,562,944.83 |
| 负债和股东权益合计 | 3,044,606,647.74 | 2,465,188,191.06 | 2,443,891,227.87 | 2,428,885,839.81 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,503,850,608.61 | 942,437,762.95 | 436,618,767.99 | 1,850,320,245.8 |
| 经营活动现金流出小计 | 1,219,833,533.4 | 786,942,922.65 | 424,022,436.83 | 1,389,720,297.62 |
| 经营活动产生的现金流量净额 | 284,017,075.21 | 155,494,840.3 | 12,596,331.16 | 460,599,948.18 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 568,230,880.76 | 378,818,811.44 | 214,245,195.91 | 968,003,005.8 |
| 投资活动现金流出小计 | 1,044,214,273.37 | 564,293,423.7 | 447,839,599.06 | 1,123,365,850.42 |
| 投资活动产生的现金流量净额 | -475,983,392.61 | -185,474,612.26 | -233,594,403.15 | -155,362,844.62 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 584,528,301.89 | 60,000,000 | - | 82,540,000 |
| 筹资活动现金流出小计 | 262,402,587.35 | 188,091,900.6 | 17,556,608.25 | 250,847,993.77 |
| 筹资活动产生的现金流量净额 | 322,125,714.54 | -128,091,900.6 | -17,556,608.25 | -168,307,993.77 |
| 汇率变动对现金及现金等价物的影响 | -2,653,777.38 | -2,133,416.11 | -603,697.95 | 1,308,872.59 |
| 现金及现金等价物净增加额 | 127,505,619.76 | -160,205,088.67 | -239,158,378.19 | 138,237,982.38 |
| 期末现金及现金等价物余额 | 545,665,901.4 | 257,955,192.97 | 179,001,903.45 | 418,160,281.64 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -160,205,088.67 | - | 138,237,982.38 |